lactam bridge is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-06-23. Numbers and descriptions here follow the published literature rather than marketing material.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
The peptide acts as a non-selective agonist at melanocortin receptors, showing affinity for MC1R, MC3R, MC4R and MC5R. Activation of MC1R on melanocytes drives the conversion of tyrosine into melanin and shifts production toward the darker eumelanin form. MC4R signalling in the central nervous system is linked to appetite and energy balance, which helps explain why reduced food intake appeared in early human studies. Effects on MC4R and on vascular tone also account for the erectile responses recorded as unexpected findings in those same trials.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
Melanocortin receptors comprise five subtypes with distinct tissue distributions and functions. Melanotan-2 is described in the literature as a non-selective agonist that engages several of these subtypes, including MC1R, MC3R, MC4R, and MC5R. MC1R is the subtype most directly linked to melanin production in skin cells. Because the compound is not subtype-selective, its observed effects in experimental settings are generally attributed to activity across multiple receptor pathways rather than to a single target.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Alpha-MSH analogue with a lactam ring |
| Molecular formula | C50H69N15O9 | Commonly cited value for the neutral peptide |
| Molecular weight | 1024.18 g/mol | Calculated for the free molecule |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water, DMSO and ethanol | Dissolution in pure water is often slow |
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.
From Penn Station: A, C, and E trains at 34th Street–Penn Station, under Eighth Avenue 1, 2, and 3 trains at 34th Street–Penn Station, under Seventh Avenue From Herald Square, one block east at Sixth Avenue: B, D, F, <F>, M, N, Q, R, and W trains at 34th Street–Herald Square station, under Broadway & Sixth Avenue
If SO3 is condensed above 27 °C, then α-SO3 forms, which has a melting point of 62.3 °C. α-SO3 is fibrous in appearance. Structurally, it is the polymer [S(=O)2(μ-O)]n. Each end of the polymer is terminated with OH groups. β-SO3, like the alpha form, is fibrous but of different molecular weight, consisting of a hydroxyl-capped polymer, but melts at 32.5 °C. Both the gamma and the beta forms are metastable, eventually converting to the stable alpha form if left standing for sufficient time. This conversion is caused by traces of water. Relative vapor pressures of solid SO3 are alpha < beta < gamma at identical temperatures, indicative of their relative molecular weights. Liquid sulfur trioxide has a vapor pressure consistent with the gamma form. Thus heating a crystal of α-SO3 to its melting point results in a sudden increase in vapor pressure, which can be forceful enough to shatter a glass vessel in which it is heated. This effect is known as the "alpha explosion".
=== Pancreatic and glycemic control === Semaglutide enhances the growth and proliferation of pancreatic beta cells, which are responsible for insulin production, while mitigating oxidative stress to reduce cell death (apoptosis). It achieves glycemic control primarily through a glucose-dependent mechanism: by binding to GLP-1 receptors on beta cells, it elevates intracellular levels of cyclic AMP (cAMP) and activates protein kinase A (PKA) and related signaling pathways. This cascade alters cellular energy dynamics, ultimately triggering the influx of calcium into the cell, which prompts the exocytosis (release) of insulin-containing vesicles into the bloodstream. Concurrently, semaglutide inhibits the release of glucagon from pancreatic alpha cell, which decreases glucose production by the liver (gluconeogenesis) and maintains blood sugar level stability, particularly preventing sharp spikes after meals. Beyond its direct action on the pancreas, semaglutide alleviates peripheral insulin resistance. It does this by upregulating phosphorylated IRS-1 and activating pathways (like AMPK/SIRT1) that promote the transport of the GLUT4 glucose transporter to cell membranes in muscle and adipose tissue, thereby increasing overall cellular glucose uptake.
=== Medicinal === For the Nuba tribe of Sudan, scars can serve a medicinal purpose; scars above the eyes are believed to improve eyesight, and scars on the temples are believed to help relieve headaches. In some cultures, scarification is used in traditional medicine to treat some illness by inserting medicine (usually herbs or powdered root) under the skin to heal a variety of infections and illnesses such as Malaria.
Sources: en.wikipedia.org
== Red blood cell modifications (secondary processing) == Red blood cell concentrates are sometimes modified to address specific needs of patients who, for different reasons, are unable to tolerate standard red blood cell concentrates.
== Intervention strategies == Aβ is the main component of the kind of amyloid plaques that form in the brains of people with Alzheimer's disease. Aβ can also form the deposits that line cerebral blood vessels in cerebral amyloid angiopathy. The plaques are composed of aggregated Aβ oligomers called amyloid fibrils, a protein fold shared by other peptides such as the prions associated with protein misfolding disease, also known as proteinopathy.
The vagina is attached to the pelvic walls by endopelvic fascia. The peritoneum is the external layer of skin that covers the fascia. This tissue provides additional support to the pelvic floor. The endopelvic fascia is one continuous sheet of tissue and varies in thickness. It permits some shifting of the pelvic structures. The fascia contains elastic collagen fibers in a 'mesh-like' structure. The fascia also contains fibroblasts, smooth muscle, and vascular vessels. The cardinal ligament supports the apex of the vagina and derives some of its strength from vascular tissue. The endopelvic fascia attaches to the lateral pelvic wall via the arcus tendineus.
=== Classification === There are exceptions, but levels of alpha-glucosidase determine the type of GSD-II an individual may have. More alpha-glucosidase present in the individual's muscles means symptoms occur later in life and progress more slowly. GSD-II is broadly divided into two onset forms based on the age symptoms occur. The infantile-onset form is usually diagnosed at 4–8 months; muscles appear normal but are limp and weak preventing the child from lifting their head or rolling over. As the disease progresses, heart muscles thicken and progressively fail. Without treatment, death usually occurs due to heart failure and respiratory weakness. The late or later onset form occurs later than one to two years and progresses more slowly than the Infantile-onset form. One of the first symptoms is a progressive decrease in muscle strength starting with the legs and moving to smaller muscles in the trunk and arms, such as the diaphragm and other muscles required for breathing. Respiratory failure is the most common cause of death. Enlargement of the heart muscles and rhythm disturbances are not significant features but occur in some cases.
President of League of Communists of Serbia Slobodan Milošević visited Kosovo in April 1987 and promised rapid action in order to protect peace and the Serbs of Kosovo. Ethnic tensions in Kosovo heated up when a Kosovo Albanian soldier opened fire on his fellow soldiers in Paraćin, in an event known as the Paraćin massacre. Then President of Serbia Ivan Stambolić wanted to make compromise, rather than fast solution. He found himself in a clash with Milošević. This conflict culminated with 8th Session and replacement of Stambolić with Petar Gračanin as President of Serbia.
Sources: en.wikipedia.org
The book presented her observations from more than 300 experiments over the span of five years, during which she attempted to discover factors necessary for the preservation of beef, eggs, and other foods. Her work was recommended for royal privilege by fellow chemist Pierre-Joseph Macquer. c. 1775: French explorer, herbalist and botanist Jeanne Baret becomes the first woman to circumnavigate the globe. c. 1775: French chemist, scientific artist and translator, Marie-Anne Paulze Lavoisier began working with her husband chemist Antoine Lavoisier. She was instrumental in the 1789 publication of her husband’s groundbreaking Elementary Treatise on Chemistry, which presented a unified view of chemistry as a field, as she drew diagrams of all the equipment used, and kept strict records that lent validity to the findings. She also translated and critiqued Richard Kirwan's 'Essay on Phlogiston and the Constitution of Acids' which led to the discovery of oxygen gas. 1776: At the University of Bologna, Italian physicist Laura Bassi became the first woman appointed as chair of physics at a university. 1776: German astronomer Christine Kirch received a respectable salary of 400 Thaler for calendar-making. See also her sister Margaretha Kirch 1782–1791: French chemist and mineralogist Claudine Picardet translated more than 800 pages of Swedish, German, English and Italian scientific papers into French, enabling French scientists to better discuss and utilize international research in chemistry, mineralogy and astronomy. c.
UNICEF spokesperson Toby Fricker stated, "There is no safe place for children anywhere across the strip right now." On 19 December, the United Nations stated Gaza was "by far the most dangerous place in the world to be a child". James Elder, a UNICEF spokesperson, called the conflict in Gaza a "war on children." On 6 January 2024, Tanya Haj-Hassan, a doctor with Doctors Without Borders, stated children in Gaza were "dying in every way possible." On 18 January 2024, the deputy executive director of UNICEF stated the suffering of children in Gaza were the "most horrific conditions I have ever seen." On 2 February 2024, the UNICEF chair stated, "The situation for children in Gaza grows bleaker every day. The world cannot abandon them." On 5 March, UNICEF called the war on Gaza "a test of human conscience" and stated that the lack of humanitarian aid in the north was worsening children's health situation. Adele Khodr, UNICEF's Middle East regional director, stated on 19 March: "The world’s inaction is shocking as more children succumb to a slow death."
Human blood is typical of that of mammals, although the precise details concerning cell numbers, size, protein structure, and so on, vary somewhat between species. In non-mammalian vertebrates, however, there are some key differences:
=== Prostate cancer === STAT5a is involved in the maintenance of integrated prostate epithelial structure and has been shown to be critical for cell viability and tumor growth. Stat5a/b is persistently active in prostate cancer cells and inhibition of STAT5a/b has resulted in large scale apoptotic death, although the specific role of STAT5a and distribution of activity remains largely unknown. Prolactin has been known to activate the JAK2-STAT5a/b pathway in both normal and malignant prostate epithelium, but again, the specific activity of STAT5a remains unknown.
==== 2200–2299 ==== Motor Vehicles (Type Approval for Goods Vehicles) (Great Britain) (Amendment) Regulations 1993 (S.I. 1993/2200) Motor Vehicles (Type Approval) (Great Britain) (Amendment) Regulations 1993 (S.I. 1993/2201) Bananas (Interim Measures) (Revocation) Regulations 1993 (S.I. 1993/2204) Wireless Telegraphy (Television Licence Fees) (Amendment) (No. 2) Regulations 1993 (S.I. 1993/2205) National Health Service (General Dental Services) Amendment Regulations 1993 (S.I. 1993/2209) Dental Vocational Training Authority Regulations 1993 (S.I. 1993/2210) Dental Vocational Training Authority (Establishment and Constitution) and Appeal Body (Specification) Order 1993 (S.I. 1993/2211) Taxes (Interest Rate) (Amendment No. 3) Regulations 1993 (S.I. 1993/2212) Friendly Societies Act 1992 (Commencement No. 6 and Transitional Provisions) Order 1993 (S.I. 1993/2213) Finance Act 1993 (Appointed Day) Order 1993 (S.I. 1993/2214) Finance Act 1993, section 12, (Appointed Day) Order 1993 (S.I. 1993/2215) National Health Service (District Health Authorities) (No.2) Order 1993 (S.I. 1993/2218) National Health Service (Determination of Districts) (No.2) Order 1993 (S.I. 1993/2219) National Health Service (General Dental Services) (Scotland) Amendment Regulations 1993 (S.I. 1993/2224) Parole Board (Scotland) Rules 1993 (S.I. 1993/2225) Transcripts of Criminal Proceedings (Scotland) Order 1993 (S.I. 1993/2226) Prison (Scotland) Amendment Rules 1993 (S.I. 1993/2227) Young Offenders (Scotland) Amendment Rules 1993 (S.I. 1993/2228) Road Traffic Act 1991 (Commencement No.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.
No national medicines agency has approved melanotan-2 for clinical use. Afamelanotide, a related but distinct peptide, holds a marketing authorisation in the European Union for a rare photosensitivity disorder. Melanotan-2 itself is handled as a laboratory chemical.
Its broad activity across melanocortin receptors makes it a tool for probing pigmentation, appetite and vascular signalling. Early trials recorded skin darkening and other effects that were not the original focus of the work. Those observations generated hypotheses that later studies have examined.
No. Melanotan-2 is manufactured synthetically. The naturally occurring peptide in the same family is alpha-melanocyte-stimulating hormone, which the body produces as part of normal endocrine and neural signalling.